BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Roche Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development     12/23/2014
Merck & Co.'s Keytruda Shrank Tumors In Hard-To-Treat Breast Cancer Patients     12/11/2014
Analysts Not Sold On Medivation, Inc.’s Xtandi as Breast Cancer Drug     12/10/2014
Novartis AG Copy Of Amgen Cancer Drug Shows Similar Efficacy     12/8/2014
Puma Biotechnology Sinks On Breast Cancer Drug NDA Delay     12/4/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Merrion Pharmaceuticals, Inc. Bids To Attract €52m Investment For Products     12/1/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
Roche, Merck & Co. Extend Immunotherapy Battle To Breast Cancer     10/17/2014
Pfizer's Palbociclib Granted FDA Priority Review     10/14/2014
Genentech's New Breast Cancer Drug Greatly Extends Survival Rates     9/30/2014
Roche’s Avastin Prolongs Life In Breast Cancer Study     9/25/2014
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche's New $152,850 Breast Cancer Drug     8/11/2014
Puma Biotechnology Shares Soar On Breast Cancer Drug Results     7/28/2014
Amgen, Bayer HealthCare's Nexavar Fails Late-Stage Breast Cancer Study     7/25/2014
 Featured Stories
Low-Fat Diet May Help Women Survive Breast Cancer, UCLA Medical Center Study     12/16/2014
No Link Between Migraine, Breast Cancer Risk, Harvard University Study Says     12/15/2014
A*STAR Scientists Uncover Gene Associated With An Aggressive Breast Cancer     12/2/2014
Increasing Skirt Size Boosts Your Breast Cancer Risk, University College London Study     9/26/2014
Is Soy A Foe To Women With Breast Cancer? Memorial Sloan-Kettering Cancer Center Study     9/8/2014
Bras Cause Breast Cancer? Apparently Not, Fred Hutchinson Cancer Research Center Study     9/5/2014
Study Ties New Gene Mutation To Major Breast Cancer Risk, The New England Journal of Medicine Reveals     8/7/2014
Birth Control Pills May Double Breast Cancer Risk, Fred Hutchinson Cancer Research Center Study     8/4/2014
Total Darkness During The Night Is A Key To Success Of Breast Cancer Therapy, Tulane University Study     7/28/2014
Association Found Between High Cholesterol And Breast Cancer, Aston University School Of Medical Sciences Study     7/7/2014
No Link Found Between Fertility Drugs And Cancers, University of Illinois Study     7/1/2014
Harmless Virus Kills Cancer And Tumor Cells, Pennsylvania State University Study     6/26/2014
Single Drug Could Soon Cure High Cholesterol, Breast Cancer, University of Missouri Study     6/19/2014
Red Meat Possibly Linked To Breast Cancer, Harvard School of Public Health Study     6/12/2014
Moles Linked To Breast Cancer Risk, Indiana University And Harvard University Study     6/11/2014
 More News
Genentech (RHHBY) Provides Update On Phase 3 MARIANNE Study In People With Previously Untreated Advanced HER2-Positive Breast Cancer     12/19/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Results From The Phase 2 Borealis-1 Trial Of Apatorsen In The Treatment Of Metastatic Bladder Cancer     12/19/2014
Inovio Pharmaceuticals (INO) Initiates DNA Immunotherapy Trial For Breast, Lung And Pancreatic Cancers     12/18/2014
Phenogen Sciences, Inc. Announces Clinical Validation Study Supporting The Use Of Brevagenplus® In Breast Cancer Risk Assessment     12/17/2014
Astellas Pharma Inc. (ALPMY) Release: Data Presented From Phase 2 Study Of Enzalutamide In Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer     12/15/2014
Immunomedics, Inc. (IMMU) Reports Preliminary Results From Pretargeted Imaging Study In Patients With Metastatic Breast Cancer     12/15/2014
Immunomedics, Inc. (IMMU) Reports Expanded Phase 1/2 Trials Confirm Activity And Good Safety Profile Of Sacituzumab Govitecan (Immu-132) In Patients With Advanced Triple-Negative Breast Cancer     12/12/2014
Synta Pharmaceuticals (SNTA) Announces Presentation Of Results From An Investigator-Sponsored Phase 1 Trial Of Ganetespib In HER2+ Metastatic Breast Cancer At The 2014 San Antonio Breast Cancer Symposium     12/12/2014
Nektar Therapeutics (CA) (NKTR) Presents Data On Target-Specific Biomarkers From Circulating Tumor Cell Sub-Study Of Phase 3 BEACON Study Of Etirinotecan Pegol (NKTR-102) In Patients With Advanced Breast Cancer     12/12/2014
Oncothyreon Inc. (ONTY) Announces Presentation Of Positive ONT-380 Data At San Antonio Breast Cancer Symposium     12/12/2014
Janssen Research & Development Release: Data From The EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented At San Antonio Breast Cancer Symposium     12/12/2014
Merrimack Pharmaceuticals Inc. (MACK) Presents Research On Innovative Pipeline For Patients With Breast Cancer At The 2014 San Antonio Breast Cancer Symposium     12/12/2014
Calithera Biosciences, Inc. (CALA) Presents Novel Pharmacodynamic Assay Data Confirming Glutaminase Inhibition In Tumor Biopsy Samples From Patients Treated With CB-839     12/11/2014
Caris Life Sciences Presents Two Studies Demonstrating Utility Of Tumor Profiling: Likelihood Of Response To Immunotherapeutics In HER2-Positive Breast Cancer And The Largest Case Series Comparing Male Breast Cancer To Female Breast Cancer Patients     12/11/2014
International Breast Cancer Study Group, Breast International Group And Merck & Co. (MRK) Announce Opening Of International PANACEA Study Of Patients With HER2+ Breast Cancer     12/10/2014